Every trade that managers of Lumito AB (publ) disclose to Finansinspektionen is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 18 October 2026, 7 filings were filed, from 5 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Insider buying of Lumito AB (publ) has been absent for the past year. The median gap between a trade and its publication by Finansinspektionen is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade.
Compared with its exchange (890 companies, median 7 filings), a count of 7 filings is typical.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
· cache
7 of 7 declarations
Lumito AB (publ) is a Swedish company operating in the health and pharmaceutical sector. It is listed on the Stockholm Stock Exchange (XSTO).
Purchases our model currently ranks for the recommendations list.
All recommendations